CFT7455

CFT7455
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T60024-1mg 1 mg

7 - 10 business days*

79.00€
TGM-T60024-5mg 5 mg

7 - 10 business days*

195.00€
TGM-T60024-1mL 1 ml

7 - 10 business days*

198.00€
TGM-T60024-10mg 10 mg

7 - 10 business days*

320.00€
TGM-T60024-25mg 25 mg

7 - 10 business days*

519.00€
TGM-T60024-50mg 50 mg

7 - 10 business days*

-
 
Description: CFT7455 (Cemsidomide) is an anti-cancer agent showing high affinity to the cereblon... more
Product information "CFT7455"
Description: CFT7455 (Cemsidomide) is an anti-cancer agent showing high affinity to the cereblon E3 ligase with a Kd of 0.9 nM. CFT7455 is an orally active degrader of zinc finger transcription factors Ikaros (IKZF1), and Aiolos (IKZF3). Target: Ligand for E3 Ligase. Smiles: [H][C@@]1(CCC(=O)NC1=O)N1C(=O)c2cccc3c(Cc4ccc(CN5CCOCC5)cc4)ccc1c23. References: David Proia, et al. Advantageous therapies for disorders mediated by ikaros or aiolos. WO2022032132A1.
Keywords: Cemsidomide
Supplier: TargetMol
Supplier-Nr: T60024

Properties

Application: Protac(R) reagent
MW: 469.53 D
Formula: C28H27N3O4

Database Information

CAS : 2504235-67-8| Matching products
KEGG ID : K11793 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CFT7455"
Write a review
or to review a product.
Viewed